Stock Track | 3D Systems Soars 5.19% as Subsidiary Systemic Bio Wins Prestigious SLAS Innovation Award

Stock Track
02-05

3D Systems Corporation (NYSE: DDD) saw its stock soar 5.19% in the pre-market trading session on Wednesday, driven by positive news surrounding its subsidiary, Systemic Bio.

Systemic Bio, a wholly-owned company of 3D Systems focused on accelerating drug discovery and development, has been named the winner of the prestigious SLAS 2025 Innovation Award. This award recognizes groundbreaking technological advancements poised to drive innovation in laboratory science and automation.

The award highlights Systemic Bio's proprietary h-VIOS™ platform, designed to accelerate drug discovery and development using bioprinted human tissues. The platform enables early identification of safety concerns, capturing risks that historically have only been discovered during clinical trials, even after non-human primate studies failed to flag such issues.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10